Indicia Production, a company specializing in the manufacture of ready-to-use culture media and sterile liquid products, has acquired METIS Biotechnologies, a company that develops, produces and markets rapid microbiological analysis solutions using flow cytometry.
The financial terms of the transaction have not been disclosed.
METIS Biotechnologies’ analytical solutions can be automated from sampling to results rendering.
They are applicable for the pharmaceutical, food processing and cosmetics industries.
The instruments and reagents on offer allow companies to carry out in-situ analysis, such as on the sterility of ultra high temperature dairy products, fruit juices and other food products.
They also detect acidophilic and acid-resistant floras in fruit juices, as well as bacteria, yeasts and molds in cosmetic products.
This acquisition enables Indicia Production to become a major player on the market by extending its current traditional microbiological media offering with the fast and tailored microbiological analysis technology using flow cytometry, developed by METIS Biotechnologies.
This will allow the company’s customers in the agrifood and cosmetics industries to improve their reactivity in the control of production.
Following the acquisition, the consolidated company will operate with 57 employees. Its turnover is estimated to reach €8 million (US$8.35 million) in 2017.